Facial Serum Formulation: Building an Active, Base and Claim That Match

Most serum formulations that fail do not fail because of a mistake. Every decision along the way was defensible. They fail because three decisions that should have been made together were made separately, and the second and third were the wrong shape for the first.

The pattern is remarkably consistent. Marketing picks an active from a trend report. Development picks a base from whatever the supplier already stocks. Legal writes a claim at the end from whatever the marketing team wants to say. Then the formula does not behave, the claim cannot be substantiated, or both.

Most serum problems are mismatches, not mistakes

A mismatch is harder to spot than a mistake because nothing looks broken. The formula is stable, the texture is pleasant, the pack is beautiful. What is wrong is that the active is at a pH where it is not at its best, or the gelling agent is fighting the electrolyte load, or the claim describes a physiological change that a cosmetic cannot substantiate.

The fix is a sequence rather than a set of skills. Choose in this order:

• The claim, written in the words that will appear on pack, in the language a customer understands.
• The active that can deliver that claim, with a route to evidence.
• The delivery system the active tolerates, rather than the one that is cheapest.
• The packaging, which for an oxygen-sensitive active is part of the delivery system, not a separate purchase.
• The test plan, which is where the claim becomes defensible or does not.

It is worth noticing that this order inverts the usual one. The claim is normally written last, and it is normally the constraint that everything else should have been designed around.

Start with what the active can and cannot tolerate

Before anything else, an active has five characteristics that determine the entire formula. Getting these from the supplier's technical data sheet, rather than assuming them, saves a development cycle:

• Solubility. Water, oil, glycol, or amphiphilic. This decides whether you are building an aqueous serum, an anhydrous blend or an emulsion.
• pH stability window. The range over which the material does not degrade. This is usually the hardest constraint in the whole project.
• Thermal stability. Whether it survives the temperatures reached during manufacture and any heat used in the process.
• Oxygen and light sensitivity. Whether the pack has to be opaque, sealed, or both.
• Charge and reactivity. Cationic actives interact with anionic thickeners, preservatives and surfactants. This is the source of the most confusing formulation behaviour.

Two of these - pH and charge - cause most of the trouble, and both are usually discovered late.

The pH conflict that catches the most brands

The classic example involves vitamin C. L-ascorbic acid is only properly active in a strongly acidic environment, typically below about pH 3.5. That is well understood.

What is less often understood at the start is that the most common gelling agent for a water-based serum - carbomer - needs a higher pH to thicken properly, because it thickens by neutralising the acid groups on the polymer chain. Formulate at pH 3 and the carbomer stays thin.

So the brief contains a contradiction before anyone has mixed anything: the active wants one pH and the texture wants another. There are legitimate ways out - different gelling systems that work at low pH, a different vitamin C derivative, or accepting a thin serum and positioning it as a watery essence - but each is a decision, and one of them has to be made deliberately.

The vitamin C forms and what each one tolerates are compared in our vitamin C comparison article.

Electrolytes quietly destroy viscosity

A related failure that surprises almost everyone: many common thickeners lose viscosity when the formula contains electrolytes. Carbomer is neutralised by base, but it is also sensitive to salt. Salts of any kind - buffer salts, sodium hyaluronate, some preservatives, some actives delivered as sodium or potassium salts - can collapse the gel.

The result is a formula that was thick during bench work and thin after a pH adjustment or the addition of a buffering salt, and nobody can explain it because the change looked trivial.

The practical response is to state the expected electrolyte load in the brief, and to test viscosity after every addition rather than only at the end. A formulator who has seen this before will ask about salts early; if nobody asks, that is information too.

Charge is the other hidden variable

Cationic materials and anionic materials attract each other, and in a cosmetic formula that attraction shows up as cloudiness, precipitation, stringiness or loss of activity. Common collisions:

• A cationic conditioning polymer with an anionic surfactant or thickener.
• A cationic active with an anionic preservative.
• Certain peptides, which are charged depending on pH, meeting an oppositely charged thickener.

None of these are exotic. They are routine and they are avoidable by writing the charge of each ingredient on the brief, which almost nobody does. Our INCI and regulation article covers naming, and the practical starting point is to ask your manufacturer which of your proposed ingredients are anionic and which are cationic.

Build the base around the active, not the other way round

Once the constraints are known, the base almost chooses itself, down to a small number of viable options:

Aqueous gel serum. Water, humectants, a gelling agent, a preservative. Good for water-soluble actives at a comfortable pH. Requires preservation and challenge testing - see our preservative article.

Anhydrous serum or oil blend. No water, so no preservative challenge and no water-driven degradation. Excellent for oil-soluble actives and for anything that oxidises in water. Limits you to oil-compatible materials.

Emulsion. Water and oil together, which widens the ingredient set but adds emulsifier selection and physical stability to the problem. The choices are set out in our emulsion formulation article.

Single-dose encapsulated fill. A format rather than a chemistry, but a relevant one: if your active oxidises, being sealed in an individual unit is a delivery advantage rather than a packaging preference. The mechanics are in our encapsulation systems article.

Notice that all four are legitimate. The question is which one your active can live in.

Then make the claim match what you built

Claims fall into two groups and the boundary between them matters.

Appearance claims describe how skin looks or feels: smoother, more radiant, more even-looking, more comfortable. These are the territory of a cosmetic and they are supportable with the right testing.

Physiological claims describe what is happening biologically: repairing tissue, treating a condition, altering structure. These are not cosmetic claims in most markets, whoever makes them.

The wording that gets brands into trouble usually sits in between and sounds harmless - "repairs the barrier", "reduces inflammation", "stimulates collagen". Each of those describes a process rather than an appearance.

The safe construction is to describe the outcome as the customer experiences it and let the ingredient list do the explaining. Our efficacy testing article and brightening claims article cover how the testing is structured for each type.

Active constraints across common families

Where the money actually goes

Three lines dominate a serum's cost, and only one of them is visible in the marketing conversation.

The active is usually the largest fill cost, sometimes by an order of magnitude. The base is cheap. The expensive hidden items are the supporting work: preservative efficacy testing, stability on the finished pack, and the claim study. Those are frequently left out of the original budget and then discovered.

If the target cost is tight, the useful question is not "how do we make the active cheaper" but "which of these three can be reduced without weakening the claim". Often the answer is the packaging finish rather than the active level. Our cost breakdown article sets out how the lines sit together.

The mismatch checklist

Run this before any sample is made. It takes an hour and saves a cycle:

• What is the claim, written exactly as it will appear on pack?
• Which active delivers it, and what is its evidence route?
• What is the active's pH window, and what pH does the gelling system need?
• What is the electrolyte load, and does the thickener tolerate it?
• Are any two ingredients oppositely charged?
• Does anything conflict - chelators with metal-containing actives, acids with pH-sensitive ones?
• Is the packaging an adequate barrier for this active?
• What test produces the number behind the claim, and who runs it?

Most projects that run into trouble at month four would have caught it here at week one. Our article on where serum projects start to go wrong describes what the failure looks like from the factory side.

Sequencing the development

A realistic order of work for a new serum:

1. Write the claim and the target market, and have the claim reviewed for permissibility before anything is mixed.
2. Select two candidate actives, not one, and obtain complete technical data on both.
3. Select the base type that suits them, and confirm the pH and viscosity can be reached.
4. Sample two or three variants against written sensory targets.
5. Commission stability and preservative testing on the preferred variant, in its final pack.
6. Commission the claim study once the formula is frozen.
7. Only then finalise artwork.

The temptation is to compress steps five and six into parallel with seven. That works only if the artwork claims nothing that the studies might not support, which is rarely the case.

How to brief it

Give the claim in final wording. Give the active by INCI name and the level you want. Give the markets, since claim and ingredient rules differ. Give the sensory target in whatever language you have - our texture article covers how to make that specific. And say which of the constraints are negotiable and which are not.

The most useful single sentence you can put in a brief is which outcome matters most if a trade-off becomes necessary: performance, texture, cost or speed. Every project eventually needs one of them to give, and the answer is different for every brand.

Where our formulation capability fits

We develop serums from the constraint end rather than the trend end, and we will flag a mismatch before sampling rather than after. Formats we run include a niacinamide and hyaluronate firming serum, a 15% vitamin C essence and collagen capsule essence, across aqueous, anhydrous and encapsulated systems.

We work with brands on private label (your brand on a proven base), OEM/ODM contract manufacturing, and full custom formula development - whichever matches where your brand is today.

Send us the claim you want to make and the active you have in mind, and we will come back with the constraints, the options and what each costs you. Start at our inquiry page, email capsulebiotech@163.com, or message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319.

General manufacturing information, not regulatory or legal advice. Claim limits vary by market.